UNSPSC 51391617: Prenylamine lactate

This classification denotes an adrenergic agent C24H27N.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6J3J6SXI7V, chemically known as benzenepropanamine, n-(1-methyl-2-phenylethyl)-.gamma.-phenyl-, 2-hydroxypropanoate, but more generally known as prenylamine lactate, which bears US NIH Compound Identifier 65557. European Medicines Agency schedules Prenylamine lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04033MIG.

Most nations, for tariff and trade purposes, schedule prenylamine lactate under HS 29214980 and SITC 51454. As of Q4 2014, PRENYLAMINE LACTATE remains US FDA's Preferred Term for this commodity. SMILES: CC(CC1CCCCC1)NCCC(C2CCCCC2)C3CCCCC3.CC(C(=O)O)O.

UNSPSC 51391617 Prenylamine lactate is a Commodity code that nominally covers a specific pharmaceutical compound, but recent state and local procurement activity under this code shows a substantial mismatch. Seminole County, Florida posted an IFB (Invitation for Bid) in mid-2026 for naloxone and drug deactivation systems—emergency response and harm-reduction supplies wholly unrelated to prenylamine lactate. The county is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors must cover all shipping and delivery costs, submit bids electronically, carry workers' compensation and commercial general liability insurance, comply with drug-free workplace and E-Verify requirements, and accept a three-month probationary termination clause. The contract runs two years with a one-year renewal option and is potentially FEMA-funded, triggering additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The code shows limited relevant recent activity. The single available opportunity (Seminole County, IFB 60459723LAS, due July 26, 2023) does not reflect the code's stated pharmaceutical scope and suggests either a tagging error or that this Commodity code sees minimal application in state and local health-sector procurement. Geographic activity is confined to Florida in the available record. Absence of additional opportunities under this code indicates either light demand for prenylamine lactate at the state and local level or systematic miscoding of acquisitions under alternative UNSPSC classifications. Firms pursuing this code should verify whether procurement officers are actually tagging naloxone, harm-reduction supplies, or other emergency-response pharmaceuticals under this Commodity designation, or whether opportunities in this space migrate to different codes altogether.